The Analyzer That Cannot Be Patched

Segment first, because it is the only control that works when patching is impossible.

• Microsegment the analyzer and its middleware into a dedicated enclave with a firewall or ACL that permits only the specific source-destination-port pairs required for the result flow. Nothing else on the 340-device VLAN can reach it, and it can reach nothing else. This single control removes most of the pen-test finding.
• Kill the unnecessary service. If the file share can be disabled in favor of the middleware's direct connection, disable it. If it cannot, restrict it to the middleware IP and monitor every connection attempt.
• Block egress completely. No internet, no email, no browsing. Terminate the obsolete protocol at the enclave boundary if the middleware can bridge it.
• Harden the host: application allow-listing if the platform supports it, USB port lockdown, local admin credential rotation, full logging shipped to the SIEM, and physical access control to the bench.
• Get detection in place: IDS signatures for the exploited protocol and an alert on any new host touching the enclave.

On the two hours: reframe the question. You are not asking for downtime; you are choosing between two hours and an unplanned outage of unknown length caused by ransomware, which would also take the middleware and the results flow. Most of the controls above need one reboot and then nothing. Present the laboratory director with a specific schedule - the same two-hour window each week, communicated a week ahead - and a documented description of the consequence of doing nothing. If the director still refuses, escalate the decision, in writing, to the CMO and CIO; the refusal then becomes a recorded risk acceptance rather than a silent blocker.

Push the vendor on evidence, then document the gap and name the acceptor.

Vendor actions:

• Request a current device security documentation package and a software bill of materials. A three-year-old document for a six-year-old device is not a security posture.
• Request a written statement of support status: last patch date, end-of-support date, known vulnerabilities, and any vendor-provided mitigation or hardening guide for the enclave configuration.
• Ask specifically whether a supported, contract-compliant mitigation exists short of the $180,000 replacement. Vendors frequently have a published workaround for customers who ask in writing.
• Escalate through procurement and legal rather than through the service engineer. Reference the security and support clauses in the contract; if there is no such clause, that is the finding for the next contract.
• Ask whether the replacement can be accelerated, leased, or staged, and whether the vendor will provide interim compensating guidance.
• If the vendor has no remedy and the device presents an exploitable risk, report the vulnerability to the vendor formally and consider reporting it through FDA's medical device cybersecurity channel. That is the mechanism that reaches the manufacturer's regulatory obligation.

Risk acceptance:

Residual risk after segmentation is accepted in writing by a named executive - the CIO and the laboratory medical director jointly, not clinical engineering. The written record should include the asset, the vulnerability, the compensating controls, the residual exposure, the review date, and the trigger that ends the acceptance (replacement installed, vendor patch, or support end). Clinical engineering owns the technical assessment and the control verification; it does not own the clinical and business consequence of an outage.

Assume the analyzer and its middleware are one failure domain, because they are.

• Define the actual recovery path. Can the analyzer be reimaged from known-good media, and how long does that take? Test the restore, including the analyzer application and its configuration, on isolated hardware. An untested recovery plan is a wish.
• Keep an offline copy. Store the image and configuration away from the network and away from the domain, or the ransomware encrypts the backup too.
• Write and rehearse a downtime procedure that the laboratory staff, not IT, can execute: manual result entry, paper requisitions, a defined reference-laboratory arrangement for high acuity tests, and a named person who decides when to divert testing. Two hours a week of planned downtime is the rehearsal slot you already have - use it.
• Examine the interface as an attack path. The result interface to the laboratory information system is bidirectional in most shops, which means a compromised analyzer can push more than results. Confirm what the middleware will accept from the analyzer, whether message content is validated, and whether the interface can be paused at the boundary without stopping the analyzer's local operation.
• Protect the downstream systems. If the interface cannot be trusted, the interface goes down before the laboratory information system does. Document the order of shutdown: analyzer enclave, interface, middleware.
• Test the queue and reconciliation. When the interface comes back, results must be reconciled against paper and no result may be double-posted. Ask the laboratory information system vendor how queued messages replay, and test it.
• Review after each rehearsal and keep the runbook in a place reachable without the network.